Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check20 days agoChange DetectedThe web page now indicates that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation.SummaryDifference3%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check64 days agoChange DetectedThe page has removed detailed information about a study on short course Daratumumab for Multiple Myeloma, including its purpose, inclusion and exclusion criteria, and specific patient requirements. Additionally, it has added the name of the study's collaborators and updated the version number.SummaryDifference35%
Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.